Dr. Brian K Link MD
Hematologist-Oncologist | Hematology & Oncology
200 Hawkins Dr Iowa City IA, 52242About
Dr. Brian Link is a hematologist oncologist practicing in Iowa City, IA. Dr. Link specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Univ Of Ia Coll Of Med- Iowa City Ia 1986
UNIV OF IA ROY J & L CARVER COM 1986
University of Ia Roy J & L Carver Com 1986
Baylor College of Medicine, Houston, Texas 1986
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Hematology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: safety and efficacy of re-treatment.
- Influences on oncologists' adoption of new agents in adjuvant chemotherapy of breast cancer.
- Delivering adjuvant chemotherapy to women with early-stage breast carcinoma: current patterns of care.
- Phase II trial of Remitogen (humanized 1D10) monoclonal antibody targeting class II in patients with relapsed low-grade or follicular lymphoma.
- Immunotherapy of non-Hodgkin's lymphoma with hLL2 (epratuzumab, an anti-CD22 monoclonal antibody) and Hu1D10 (apolizumab).
- Post-treatment surveillance of patients with lymphoma treated with curative intent.
- Days of prophylactic filgrastim use to reduce febrile neutropenia in patients with non-Hodgkin's lymphoma treated with chemotherapy.
- Monoclonal antibody therapy of B cell lymphoma.
- Antibody therapy of lymphoma.
- Effect of clinical characteristics on neutropenia-related inpatient costs among newly diagnosed non-Hodgkin's lymphoma cases during first-course chemotherapy.
- Improved survival of follicular lymphoma patients in the United States.
- Clinical protocol: phase I study of an adenovirus/prostate-specific antigen vaccine in men with metastatic prostate cancer.
- Population-based assessment of hospitalizations for neutropenia from chemotherapy in older adults with non-Hodgkin's lymphoma (United States).
- Monoclonal antibodies in lymphoma: the first decade.
- First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial.
Treatments
- Lymphoma
- Leukemia
- Extra Corporeal Shockwave Therapy
Dr. Brian K Link MD's Practice location
Iowa City, IA 52242Get Direction
Dr. Brian K Link MD's reviews
Write ReviewPatient Experience with Dr. Link
Recommended Articles
- The Link Between Melatonin and Lymphoma
There’s always room for improvement when it comes to the experience and outcomes of cancer treatment. Fortunately, scientists are constantly researching new, better ways to do so. Although standard treatment remains mostly the same for now, the medical community is making great strides in...
- Treatment Options of Multiple Myeloma
A team led by a consultant haematology specialist takes care of you if you are a multiple myeloma patient. The team discusses your situation and suggests the best treatment for you, but you will finally decide.It may be paramount to compile a list of questions which you will ask the specialist...
- 7-year-old with Lymphoma Joins and Inspires Lacrosse Team
Sports have a way of bringing together families, strangers, and communities. All over the world people celebrate games and competitions and use them to lift people’s spirits and strengthen bonds. Sporting events are also frequently used to raise awareness about important causes, whether locally or...
- How to Deal with Lymphoma Treatment Fatigue
Treatment fatigue is a very common problem among lymphoma patients. Whether the patient is doing pharmaceutical treatments, chemotherapy, or other treatments, they will likely lead to fatigue and a feeling of being burnt out.This article will go over what treatment fatigue is, symptoms that are...
- What Are Lymphocytes?
A lymphocyte is a type of white blood cell (WBC) that has a significant function in the body's immune system. Lymphocytes function by properly responding to infectious microorganisms and other foreign invaders in the body. Lymphocytes can work alone, but some of them are also capable of...
- Promising Results for Hodgkin Patients Using This Therapy
Researcher Dr. Bradford S. Hoppe and his colleagues at the University of Florida College of Medicine have recently found that the addition of proton therapy to first-line chemotherapy regimens may improve outcomes for patients with Hodgkin lymphoma.Lymphoma is classically treated with both...
Nearby Providers
- Dr. Daniel Alberto Vaena MD200 Hawkins Dr Iowa City IA 52242
- Dr. Susan L Roeder DO200 Hawkins Dr Iowa City IA 52242
- Dr. Ahmad M Wehbe M.D200 Hawkins Dr Iowa City IA 52242
- Dr. Lori J Rosenstein M.D.200 Hawkins Dr Iowa City IA 52242
- Dr. Scott Douglas mccoskey Miller MD613 E Bloomington St Iowa City IA 52245
- Dr. Nelson Shu-sang Yee MD200 Hawkins Dr Iowa City IA 52242